Questions from a US regulator have prompted Anbang Insurance to drop an application for approval of its $1.57bn buyout of Fidelity & Guaranty Life, the latest regulatory hurdle faced by the Chinese company regarding a US acquisition.
美国监管机构发出的疑问，促使安邦保险(Anbang Insurance)放弃申请批准其以15.7亿美元收购美国信保人寿(Fidelity & Guaranty Life)。这是manbetx3.0 企业在美国收购遭遇的最新一例监管障碍。
您已阅读13%（342字），剩余87%（2290字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。